Study to Evaluate the Efficacy and Safety of VQW-765 for the On-Demand Treatment of Social Anxiety Disorder

NCT07221578 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

500

Enrollment

INDUSTRY

Sponsor class

Conditions

Social Anxiety Disorder (SAD)

Interventions

DRUG: VQW-765
DRUG: Placebo

Sponsor

Vanda Pharmaceuticals